1. Home
  2. HAO vs ATNM Comparison

HAO vs ATNM Comparison

Compare HAO & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAO
  • ATNM
  • Stock Information
  • Founded
  • HAO 2018
  • ATNM 2000
  • Country
  • HAO China
  • ATNM United States
  • Employees
  • HAO N/A
  • ATNM N/A
  • Industry
  • HAO
  • ATNM Biotechnology: Pharmaceutical Preparations
  • Sector
  • HAO
  • ATNM Health Care
  • Exchange
  • HAO NYSE
  • ATNM Nasdaq
  • Market Cap
  • HAO 4.2M
  • ATNM 51.5M
  • IPO Year
  • HAO 2024
  • ATNM N/A
  • Fundamental
  • Price
  • HAO $1.38
  • ATNM $1.57
  • Analyst Decision
  • HAO
  • ATNM Strong Buy
  • Analyst Count
  • HAO 0
  • ATNM 3
  • Target Price
  • HAO N/A
  • ATNM $4.67
  • AVG Volume (30 Days)
  • HAO 26.6K
  • ATNM 492.9K
  • Earning Date
  • HAO 07-25-2025
  • ATNM 08-04-2025
  • Dividend Yield
  • HAO N/A
  • ATNM N/A
  • EPS Growth
  • HAO N/A
  • ATNM N/A
  • EPS
  • HAO 0.19
  • ATNM N/A
  • Revenue
  • HAO $48,970,924.00
  • ATNM N/A
  • Revenue This Year
  • HAO N/A
  • ATNM N/A
  • Revenue Next Year
  • HAO N/A
  • ATNM N/A
  • P/E Ratio
  • HAO $7.01
  • ATNM N/A
  • Revenue Growth
  • HAO 15.04
  • ATNM N/A
  • 52 Week Low
  • HAO $0.84
  • ATNM $1.03
  • 52 Week High
  • HAO $167.50
  • ATNM $8.64
  • Technical
  • Relative Strength Index (RSI)
  • HAO 51.84
  • ATNM 52.22
  • Support Level
  • HAO $1.29
  • ATNM $1.41
  • Resistance Level
  • HAO $1.41
  • ATNM $1.63
  • Average True Range (ATR)
  • HAO 0.10
  • ATNM 0.11
  • MACD
  • HAO 0.01
  • ATNM 0.01
  • Stochastic Oscillator
  • HAO 66.31
  • ATNM 59.72

About HAO HAOXI HEALTH TECHNOLOGY LTD

Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. Haoxi has been rooted in the field of local online effect marketing for many years, serving customers in various industries at home and abroad, and its main business is the medical industry. It generates its revenue by providing one-stop online marketing solutions, in particular online short video marketing solutions, to advertisers through its media partners. The company provides customized marketing solutions by planning, producing, placing, and optimizing online ads, especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: